Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Efinaconazole solution?

See the DrugPatentWatch profile for Efinaconazole

Efinaconazole solution is a topical antifungal medication used for the treatment of onychomycosis, a fungal infection of the nails. It works by inhibiting a key enzyme, lanosterol 14α-demethylase, which is essential for ergosterol synthesis in fungal cell membranes [1]. Disrupting ergosterol synthesis weakens the fungal cell membrane, leading to fungal cell death [1].

How does efinaconazole solution treat nail fungus?


Efinaconazole solution is applied directly to the affected nails. Its mechanism of action involves inhibiting the enzyme lanosterol 14α-demethylase, a crucial component in the production of ergosterol [1]. Ergosterol is a vital building block for fungal cell membranes. By blocking its synthesis, efinaconazole destabilizes the fungal cell membrane, ultimately causing the fungus to die [1].

When did efinaconazole solution become available?


Efinaconazole solution was approved by the U.S. Food and Drug Administration (FDA) in July 2014 [1].

What are the potential side effects of efinaconazole solution?


The most common side effects reported with efinaconazole solution include application site reactions such as pain, itching, redness, and stinging or burning [1].

Can efinaconazole solution be used by everyone?


Efinaconazole solution is intended for topical use only and is not for ophthalmic, oral, or intravaginal use [1]. It is also important to inform your doctor about any existing medical conditions or other medications you are taking before starting treatment.

How does efinaconazole solution compare to other nail fungus treatments?


Efinaconazole is one of several topical antifungal treatments available for onychomycosis. Other common topical treatments include ciclopirox and efinaconazole. Oral antifungal medications, such as terbinafine and itraconazole, are also used but carry a higher risk of systemic side effects and drug interactions. The choice of treatment often depends on the severity and extent of the infection, as well as patient factors and physician preference.

What is the patent status of efinaconazole?


Information regarding the specific patent status and expiry dates for efinaconazole can be found on specialized databases like DrugPatentWatch.com, which tracks pharmaceutical patents and exclusivity periods [2]. Patents protect the intellectual property of drug manufacturers, influencing market exclusivity and the potential for generic competition.

How effective is efinaconazole solution?


Clinical trials have demonstrated the efficacy of efinaconazole solution in achieving mycological cure and clinical improvement for onychomycosis [1]. The success rates can vary among patients.

Where can I find more information on efinaconazole?


Additional details regarding efinaconazole, including prescribing information and clinical study data, are available through resources such as the FDA's Orange Book and pharmaceutical information websites [1]. DrugPatentWatch.com provides patent information relevant to the drug's market lifecycle [2].

Sources:
1. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205405s000lbl.pdf
2. https://drugpatentwatch.com/



Other Questions About Efinaconazole :

Efinaconazole jublia approval date? Efinaconazole jublia approval date? Efinaconazole jublia approval date? Efinaconazole jublia approval date?